Global Infant and Maternal RSV Immunization Market: Insights and Strategic Analysis

CHALLENGE

A consulting firm approached BTHT to conduct a detailed market research project on the global landscape of infant and maternal immunization against Respiratory Syncytial Virus (RSV). The client aimed to gain a comprehensive understanding of the market, focusing on the strategies and product positioning of leading RSV immunization companies. They were particularly interested in recent and upcoming product launches, manufacturing capabilities, and the commercial positioning of RSV vaccines. Additionally, they sought to gather insights from key stakeholders and decision-makers in the field to inform their strategy and market positioning.

BTHT APPROACH

To address the project’s objectives, BTHT assembled a team of experts with extensive knowledge of RSV immunization and related market dynamics. Our approach included gathering insights from two primary groups:

• Target 1:
  • RSV Immunization Manufacturers
  • Key manufacturers of RSV immunization products
  • Specialists in RSV Market Access & Pricing
  • RSV Research & Development experts
  • Leads in RSV Commercial & Marketing
  • Professionals in RSV Public Affairs
  • Experts in RSV Medical Affairs
• Target 2:
  • Key Decision-Makers
  • Members of NITAG, Payers, and HTA bodies
  • Local procurement authorities
  • Scientific societies and Key Opinion Leaders (KOLs)
  • Healthcare Providers (HCPs)

BTHT team members coordinated and attended a series of detailed interviews for the client and these professionals to ensure smooth communication and maintain confidentiality.

OUTCOME

Our detailed and strategic approach aimed to provide the client with valuable experts to gain insights into the RSV Immunization. n. Their comprehensive analysis enabled the client to make informed decisions and develop effective strategies for different country markets.